ORGASM INC. Orgasm Inc. outlines the pharmaceutical industry–sponsored classification, diagnosis and marketing of FSD — female sexual dysfunction — as a disease suffered by “43 percent of women,” and the subsequent race for a lucrative cure. Innovations detailed include the Orgasmatron, a jerry-built spinal-implant doohickey, testosterone patches and the clinical trials of a cream developed by Vivus, whose offices director Liz Canner infiltrates. Doing the on-camera investigator-narrator thing, Canner sticks to the established formula of strained-gonzo muckraking, including stock-footage asides and devastatingly unfunny animations. There’s plenty of inherent absurdity in the marketing-speak from Vivus (“... working closely [with physicians] to develop this disease entity ...”) and the tests applied at the headquarters of a Chicago-based FSD clinic (“You’ll be wearing these 3-D glasses, you’ll be watching an erotic video ...”). Instead of giving the snake-oil salesmen (and -women) enough rope, though, Canner smothers irony with condescending indignation. Too scattered in its arguments and piecemeal in its sources to weave together a convincing institutional condemnation — and the one FDA advisory panel we see does its work quite well, thank you — Orgasm Inc. attacks Big Pharma with little more than sex-positive platitudes, funky-mama coffee-shop strumming and the usual “We as a society ...” and “Our culture has made ...” conclusions. (Nick Pinkerton) (Sunset 5)
Get the This Week's Top Stories Newsletter
Every week we collect the latest news, music and arts stories — along with film and food reviews and the best things to do this week — so that you’ll never miss LA Weekly's biggest stories.